From the Bench to Bedside: Rho Kinase (ROCK) Inhibitors as a Therapy for Glaucoma
From Michael Hawkes on September 9th, 2020
Drs. Elizabeth Martin and Padhu Pattabiraman present the Science of Disease Grand Rounds in September. During their presentation they discuss glaucoma and Rho kinase inhibitors in the clinic and in the laboratory.